Abstracts for Summer 2015

Total Page:16

File Type:pdf, Size:1020Kb

Abstracts for Summer 2015 2015 SUMMER RESEARCH PROGRAM STUDENT ABSTRACTS This page left blank 2 Contents Preface………………………………………………………… 5 Acknowledgements ………………………………………… 7 Lab Research Ownership …………………………………. 9 Index List of Medical Students ………………………………... 11 List of Undergraduate Students ……………………….. 12 List of International Medical Students ………………… 13 Abstracts – Medical Students …………………………… 14 Abstracts – Undergraduates ……………………………. 118 Abstracts – International Medical Students ……..…….. 163 3 This page left blank 4 Preface The University of Texas Medical School at Houston (UTMSH) Summer Research Program provides intensive, hands-on laboratory research training for MS-1 medical students and undergraduate college students under the direct supervision of experienced faculty researchers and educators. These faculty members’ enthusiasm for scientific discovery and commitment to teaching is vital for a successful training program. It is these dedicated scientists who organize the research projects to be conducted by the students. The trainee’s role in the laboratory is to participate to the fullest extent of her/his ability in the research project being performed. This involves carrying out the technical aspects of experimental analysis, interpreting data and summarizing results. The results are presented as an abstract and are written in the trainees’ own words that convey an impressive degree of understanding of the complex projects in which they were involved. To date, more than 1,900 medical, college, and international medical students have gained research experience through the UTMSH Summer Research Program. Past trainees have advanced to pursue research careers in the biomedical sciences, as well as gain an appreciation of the relationship between basic and clinical research and clinical practice. UTMSH student research training is supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and/or by financial support from the Dean and the departments and faculty of the medical school and School of Dentistry. Biomedical science education remains a vital and integral part of our nation’s interests. The UTMSH Summer Research Program, and the dedication of our faculty and administration exemplify the institution’s commitment to training and educating the future leaders in our biomedical scientific communities. Gary C. Rosenfeld, Ph.D. Director, Summer Research Program Associate Dean for Educational Programs 5 This page left blank 6 Acknowledgements This publication marks the completion of the twenty-sixth year of The University of Texas Medical School at Houston’s (UTMSH) Summer Research Program. The longevity and success of the program are rooted in the overwhelming support received from the deans, faculty, staff and students of the medical school. Indicative of this support is the administrative assistance and financial support for the Program’s college and medical students provided by UTMSH. Sincere appreciation is expressed to Dean Giuseppe Colasurdo M.D. and Patricia M. Butler, M.D., Vice Dean, Office of Educational Programs who continue to ensure the yearly success of the Summer Research Program. Major financial assistance for medical students has also been provided through a short term research grant by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; 5 T32 DK007676). Negotiated cooperative agreements with several international medical schools have been set up to offer tailored research programs at UTMSH for selected foreign medical students who interact fully with the other students in the Summer Research Program. The success of the Summer Research Program depends primarily on the faculty who volunteer to mentor the trainees. These dedicated educators organize and guide the research projects that includes for each student data analysis, preparation of an abstract and public presentation of results. Our sincere appreciation to all faculty mentors. 7 This page left blank 8 Lab Research Ownership Publication and/or Disclosure Each student participating in this program is required to read, agree to, and sign this disclosure form. The original signed copy is on file in the Summer Research Program office; the student and their faculty mentors are each furnished with a copy. “In reference to the laboratory research you will perform this coming summer through The University of Texas Medical School at Houston’s Summer Research Program, you are required to comply with the standard restrictions regarding participation in the Summer Research Program: “All of your laboratory research is CONFIDENTIAL and although your abstract will be available through our website, you cannot independently disclose or publish any research findings or data in any form (including at meetings or conferences) without the express prior written approval of The University of Texas Medical School at Houston. If you wish to submit your abstract to any third party, you must first contact your faculty mentor no less than three (3) weeks prior to any deadlines in order to obtain the necessary written approvals. “Because your research was generated from ideas and funds that originated with your faculty mentor and The University of Texas Medical School at Houston, ownership of any data generated by you during the Summer Research Program belongs to The University of Texas Medical School at Houston or the Principle Investigator (PI).” 9 This page left blank 10 Medical Students Page Page Last Name First Name Last Name First Name # # Abdelaziz Abed 15 Lahiri Sharmistha 64 Ahn Stephanie 16 Liu Victor 66 Aria Alexander 17 Lopez Carmen 67 Beach Richard 18 Martin Clay 69 Benoist Logan 19 McMenemy Madison 70 Bowers Kyle 20 Minifee Chris 72 Caldwell Kelly 21 Minzenmayer Andrew 73 Carroll Melanie 22 Mitchell Nicholas 74 Carter Dalton 23 Mitchell Thomas 75 Covey Sarah 25 Nguyen Justin 76 Dean Riley 26 Patel Sagar 77 Deleija Juan 28 Peery Travis 78 Diffley Michael 29 Poi Tyler 79 Ding Karen 30 Price James 81 Dooley Matthew 32 Riojas Justin 83 Dursteler Amy 33 Rivas Orlyn 85 Eguia Arturo 34 Rivera Marvin 86 Emelogu Ikenna 35 Rosales Santillan Monica 87 Engelhardt Margaret 36 Royalty Samantha 88 Freemyer Benjamin 37 Sadd Corey 90 Gants Shavonia 38 Schiffer Walter 91 Gibson Anthony 40 Schrock Nicole 92 Gonzalez Adam 42 Schroeder Andrew 94 Grable Cullen 43 Sharp Bruce 95 Gu Joshua 44 Shaw Jacob 97 Ha Lina 45 Tewari Ankita 99 Henchcliffe Blake 46 Valilis Evangelia 101 Hildebrandt Aubrey 47 van Brummen Alexandra 102 Ho Kim-Trang 48 Villegas Natacha 104 Howard Ericka 49 Wang Margaret 105 Huang Neal 50 Warren Benjamin 106 Hurley Matthew 52 Webb Ashley 107 Hurling Jermaine 53 Wheeler Austin 109 Huynh Jonathan 55 Wu Joanna 110 Igbinoba Randy 56 Xiao Albert 111 Jenner Zachary 57 Yanney Rayce 112 Johnson Margaret 59 Yao Chen 114 Jones Neal 60 Yazdani Laila 115 Karim Tahseen 61 Zuniga Joshua 117 Karnes Paden 62 11 Undergraduate Students Page Page Last Name First Name Last Name First Name # # Alexander Alex 119 Ozguc Fatma 140 Awano Ebore 120 Patlan Mario 141 Barahona Kelvin 121 Pernik Mark 142 Borden Kylie 122 Rae Meredith 143 Chen (Wu) Alissa 123 Raina Abe 144 Costantini Matteo 124 Rivera Angel 145 Devakottai Sundar 126 Rodriguez Efrain 147 Dinh Nhi 127 Rogers John 148 Do Megan 128 Schnupp Trevor 149 Estrada Darlene 129 Schwab Cara 150 Folkerts Madeline 130 Sheena Brittney 151 Gadot Ron 131 Tseng Luke 152 Haeberle Heather 132 Tucker Sara 153 Hanif Sarah 133 Westerman Kimberly 154 Hayes Jane 134 Won Michelle 155 Hsiao Thomas 135 Yang Grace 156 Jeong Suhyun 136 Yin Caroliina 157 Kissoon Kimberley 137 Youn Sean 159 Landis Henry 138 Zhou Allen 161 Ling Han 139 12 International Medical Students Page Last Name First Name # Chen Yongyan 164 Hayashi Atsushi 165 Higashi Saki 167 Jiang Hongyue 169 Li Guilin 171 Lin Wei Ting 172 Saijo Saki 173 Sun Le 174 Wang Yiman 175 Xie Yizhao 177 Xu Yunze 178 Yamazaki Ai 179 Zhao Zhicong 180 14 Medical Students 14 2015 Summer Research Program Office of Educational Programs Medical Student ABSTRACT Comparing Osteocalcin in Older Trauma Patients who Suffered Fractures Based on Type 2 Diabetes Status Abed Abdelaziz The University of Texas at Houston Medical School Class of 2018 Sponsored by: Catherine Ambrose, PhD, Department of Orthopedic Surgery; Nahid Rianon, MD, DrPH, Department of Internal Medicine – Geriatric and Palliative Medicine Supported by: National Institute of Diabetes and Digestive and Kidney Diseases, 2T35DK007676-22 Key Words: Diabetes, Fracture Risk, Osteocalcin, Preventative Care Patients with type 2 diabetes (T2D) are at an increased risk of fracture. There is currently no consistent indicator of this risk. Fractures in T2D patients with non-osteoporotic bone density levels have led to discussions about investigating markers of bone turnover, e.g., osteocalcin, as an indicator of the fracture risk in the diabetic population. Osteocalcin is an osteoblast-specific secreted protein that is a marker of bone turnover and formation. Previous studies have shown osteocalcin levels to be decreased in T2D patients compared to non-diabetics. The hypothesis was that mean total osteocalcin levels in the fracture patients with T2D would be significantly lower than those without diabetes. The project involved a cross-sectional study of Memorial Hermann trauma patients who were at least 50 years of age and suffered a femoral, acetabular, or vertebral fracture between March 2012 and May 2015. Patients were grouped into diabetic and non-diabetic groups based on a positive diabetes diagnosis in their medical
Recommended publications
  • INVITED SPEAKERS (INV) Presentation: Monday, September 28, 2015 from 10:30 – 11:00 in Room Congress Saal
    INVITED SPEAKERS (INV) Presentation: Monday, September 28, 2015 from 10:30 – 11:00 in room Congress Saal. INV01 Redefining Virulence: Bacterial Gene Expression during INV03 Human Infection Breath-taking viral zoonosis: Lessons from influenza viruses H. L. T. Mobley T. Wolff University of Michigan Medical School, Department of Robert Koch-Institut, Division 17, Influenza viruses and other Microbiology and Immunology, Ann Arbor, United States Respiratory Viruses, Berlin, Germany Investigators identifying virulence genes at first did so by The World Health Organization recently expressed concerns about examining transposon mutants or individual gene mutations. an unprecedented diversity and geographical distribution of Mutants of bacterial pathogens were then assessed in animals, influenza viruses currently circulating in animal reservoirs. This whose symptoms mimicked human disease. Later, genome-wide includes an increase in the detection of animal influenza viruses screens (STM, IVET, IVIAT) were developed whereby genes and that co-circulate and exchange viral genes giving rise to novel virus proteins that influence virulence could be identified. These efforts strains. As the avian and porcine host reservoirs have in the past led to our conventional view of microbial virulence, with its focus contributed essentially to the genesis of human pandemic influenza on adhesins, iron acquisition, toxins, secretion, and motility, as viruses causing waves of severe respiratory disease on a global well as on those bacteria with genes such as on horizontally scale, this is a notable situation. transferred pathogenicity-associated islands that are not found in Zoonotic transmissions of avian influenza viruses belonging to the commensal strains. Now, however, we also must consider what H5N1 or H7N9 subtypes have been well documented in recent metabolic pathways are in play when microbial pathogens infect years.
    [Show full text]
  • | Hao Wanatha Maria Del Contatta Datum
    |HAO WANATHA MARIAUS009844679B2 DEL CONTATTA DATUM (12 ) United States Patent ( 10 ) Patent No. : US 9 ,844 , 679 B2 Nayfach - Battilana ( 45 ) Date of Patent : * Dec . 19 , 2017 (54 ) NANOPARTICLE - SIZED MAGNETIC (56 ) References Cited ABSORPTION ENHANCERS HAVING THREE - DIMENSIONAL GEOMETRIES U . S . PATENT DOCUMENTS ADAPTED FOR IMPROVED DIAGNOSTICS 4 , 106 ,488 A 8 / 1978 Gordon AND HYPERTHERMIC TREATMENT 4 ,303 ,636 A 12/ 1981 Gordon ( 71 ) Applicant: Qteris, Inc. , San Rafael, CA (US ) ( Continued ) ( 72 ) Inventor : Joseph N . Nayfach - Battilana , San FOREIGN PATENT DOCUMENTS Rafael , CA (US ) EP 0040512 B1 11 / 1981 EP 0136530 A16 /1988 (73 ) Assignee : Qteris, Inc. , San Rafael , CA (US ) (Continued ) ( * ) Notice : Subject to any disclaimer , the term of this patent is extended or adjusted under 35 OTHER PUBLICATIONS U . S . C . 154 ( b ) by 903 days. “ Krishna et al ., Unusual size -dependent magnetization in near This patent is subject to a terminal dis hemispherical Co nanomagnets on SiO . sub . 2 from fast pulsed laser claimer . processing” , J . Appl. Phys. 103 , 073902 (2008 ) (“ Krishna ” ) .* (Continued ) ( 21 ) Appl . No .: 14 /044 , 251 Primary Examiner — Joseph Stoklosa (22 ) Filed : Oct. 2 , 2013 Assistant Examiner — Adam Avigan (74 ) Attorney , Agent, or Firm — Marek Alboszta (65 ) Prior Publication Data US 2014 /0172049 A1 Jun . 19 , 2014 (57 ) ABSTRACT Nanoparticle- sized magnetic absorption enhancers (MAES ) Related U . S . Application Data exhibiting a controlled response to a magnetic field , includ ing a controlled mechanical response and an inductive (62 ) Division of application No . 12 /925 ,904 , filed on Nov. thermal response . The MAEs have a magnetic material that 1 , 2010 , now Pat .
    [Show full text]
  • Rope Parasite” the Rope Parasite Parasites: Nearly Every AuSC Child I Ever Treated Proved to Carry a Significant Parasite Burden
    Au#sm: 2015 Dietrich Klinghardt MD, PhD Infec4ons and Infestaons Chronic Infecons, Infesta#ons and ASD Infec4ons affect us in 3 ways: 1. Immune reac,on against the microbes or their metabolic products Treatment: low dose immunotherapy (LDI, LDA, EPD) 2. Effects of their secreted endo- and exotoxins and metabolic waste Treatment: colon hydrotherapy, sauna, intes4nal binders (Enterosgel, MicroSilica, chlorella, zeolite), detoxificaon with herbs and medical drugs, ac4vaon of detox pathways by solving underlying blocKages (methylaon, etc.) 3. Compe,,on for our micronutrients Treatment: decrease microbial load, consider vitamin/mineral protocol Lyme, Toxins and Epigene#cs • In 2000 I examined 10 au4s4c children with no Known history of Lyme disease (age 3-10), with the IgeneX Western Blot test – aer successful treatment. 5 children were IgM posi4ve, 3 children IgG, 2 children were negave. That is 80% of the children had clinical Lyme disease, none the history of a 4cK bite! • Why is it taking so long for au4sm-literate prac44oners to embrace the fact, that many au4s4c children have contracted Lyme or several co-infec4ons in the womb from an oVen asymptomac mother? Why not become Lyme literate also? • Infec4ons can be treated without the use of an4bio4cs, using liposomal ozonated essen4al oils, herbs, ozone, Rife devices, PEMF, colloidal silver, regular s.c injecons of artesunate, the Klinghardt co-infec4on cocKtail and more. • Symptomac infec4ons and infestaons are almost always the result of a high body burden of glyphosate, mercury and aluminum - against the bacKdrop of epigene4c injuries (epimutaons) suffered in the womb or from our ancestors( trauma, vaccine adjuvants, worK place related lead, aluminum, herbicides etc., electromagne4c radiaon exposures etc.) • Most symptoms are caused by a confused upregulated immune system (molecular mimicry) Toxins from a toxic environment enter our system through damaged boundaries and membranes (gut barrier, blood brain barrier, damaged endothelium, etc.).
    [Show full text]
  • Gram Positive Bacteria.Pdf
    Taxonomy of gram-positive bacteria High G+C content in DNA Low G+C content in DNA Actinobacteria Firmicutes Molicutes • Actinomyces • Bacillus • Mycoplasma • Streptomyces • Clostridium • Ureaplasma • Nocardia • Lactobacillus • Acholeplasma • Corynebcaterium • Listeria • Mycobacterium • Erysipelothrix • Micrococcus • Staphylococcus • Propionibacterium • Gardnerella • Streptococcus • Bifidobacterium • Enterococcus Actinomyces • Hypha-like filamentous cells • Facultatively anaerobic/anaerobic, • Commensal of skin • Grow slowly, prefer anaerobic condition A. israelii – actinomycosis – cervicofacial (poor oral hygiene, invasive dental procedure) thoracic, abdominal, pelvic, CNS -abscesses • Treatment – penicillin, erythromycin, clindamycin prolonged therapy (4-12 m) Nocardia • Strict aerobic rods • Cell wall – mycolic acids, arabinosa, galactose, meso-diaminopimelic acid weakly acid –fast • N. asteroides, N. brasiliensis • Bronchopulmonary disease (immunocompromised patiants) • Cutaneous infections – mycetoma, lymphocutaneous i., cellulitis, abscesses • Treatment – sulfonamides, 6 w., surgery Corynebacterium • Cell wall with short mycolic acids, meso-DAP, arabinose, galactose • Metachomatic granules • Aerobic, facultativly anaerobic, non motile • Associated wit human disease: • C. diphtheriae, C. jejkeium, C. urealiticum, Corynebacterium diphtheriae • Diphtheria – bacteria infected with β-phage • Diphtheria toxin – AB toxin, inhibits protein synthesis by inactivating EF-2 • Pediatric disease – respiratory diphtheria, • Sore throat, low-grade
    [Show full text]
  • IDSA Guidelines for Preclinical Microbiology and Infectious Diseases
    IDSA Guidelines for Preclinical Microbiology and Infectious Diseases Frederick Southwick,M.D., Peter Katona, M.D., Carol Kauffman, M.D., Sara Monroe, M.D., Liise-anne Pirofski, M.D., Carlos del Rio, M.D., Harry Gallis, M.D., and William Dismukes, M.D. Key Facts and Concepts in Microbiology and Infectious Diseases Viral Infections Editorial comment: A major problem for most of the viruses is that many have similar clinical presentations, making case-based teaching somewhat more difficult. But examples of viruses primarily attacking different organ systems may prove helpful. Also distinct skin rashes should be shown to allow the students to become familiar with characteristic skin lesions of measles, small pox, chicken pox (varicella), rubella, and herpes simplex and other human herpes viruses. 1. Structure and Classification A. Nucleic acid – multiple forms • RNA viruses . Single stranded + RNA (polio, West Nile) . Single stranded – RNA requires viral RNA polymerase to synthesize + mRNA (influenza, measles) . Double stranded RNA requires viral RNA polymerase (rotavirus) . Single stranded +RNA to DNA incorporated into host cell genome, requires a viral reverse transcriptase (retroviruses, HIV) • DNA viruses, with the exception of pox viruses all require host RNA polymerase . Single-stranded DNA (parvoviruses) . Double stranded linear DNA viruses (herpesviruses, adenovirus) . Double stranded circular DNA (hepadnaviruses, papillomaviruses) B. Capsid formation 2. Life cycles and Pathogenesis – review of different strategies used by viruses • Enveloped . Matrix (M) protein . Spike formation . Budding • Nonenveloped . Apoptosis . Cell lysis 3. Epidemiology • Secretions: aerosolization, hand to mucous membranes • Transcutaneous • Fecal-oral • Sexual • Hematogenous (blood transfusions, needle sticks) • Arthropodborne 4. Sites of infection and types of disease caused • Respiratory tract • Gastrointestinal tract and liver • Skin • Nervous system 5.
    [Show full text]
  • DGCR8 Deficiency Impairs Macrophage Growth and Unleashes
    Published Online: 26 March, 2021 | Supp Info: http://doi.org/10.26508/lsa.202000810 Downloaded from life-science-alliance.org on 2 October, 2021 Research Article DGCR8 deficiency impairs macrophage growth and unleashes the interferon response to mycobacteria Barbara Killy1 , Barbara Bodendorfer1,Jorg¨ Mages2 , Kristina Ritter3, Jonathan Schreiber1 , Christoph Holscher¨ 3,4, Katharina Pracht5 , Arif Ekici6 , Hans-Martin Jack¨ 5, Roland Lang1 The mycobacterial cell wall glycolipid trehalose-6,6-dimycolate STAT1 and IRF5 and thereby suppresses type I IFN responses (Tang (TDM) activates macrophages through the C-type lectin receptor et al, 2009). Further important miRNAs controlling innate immune MINCLE. Regulation of innate immune cells relies on miRNAs, which responses are miR-21, miR-125b, and miR-142-3p, which impair may be exploited by mycobacteria to survive and replicate in translation of the adapter protein MYD88 (Xue et al, 2017) and macrophages. Here, we have used macrophages deficient in the regulate mRNA levels of the pro-inflammatory cytokines TNF and microprocessor component DGCR8 to investigate the impact of IL-6 (Rajaram et al, 2011; Liu et al, 2016). In contrast, miR-155 pro- miRNAontheresponsetoTDM.DeletionofDGCR8inbonemarrow motes inflammatory immune responses by attenuating the expression progenitors reduced macrophage yield, but did not block macro- of key negative regulators, including the inhibitor of IFN signaling SOCS1 phage differentiation. DGCR8-deficient macrophages showed re- (Yao et al, 2012; Chen et al, 2013; Li et al, 2013; Rao et al, 2014)andthe duced constitutive and TDM-inducible miRNA expression. RNAseq phosphatase SHIP1 (Wang et al, 2014). Thus, miRNAs represent a fun- analysis revealed that they accumulated primary miRNA transcripts damental regulatory layer in innate immune responses by fine-tuning and displayed a modest type I IFN signature at baseline.
    [Show full text]
  • Gram Positive & Negative Cocci Disease
    ALAGAPPA UNIVERSITY [Accredited with ‘A+’ grade by NAAC (CGPA:3.64) in the Third Cycle and graded as category I university by MHRD-UGC] [A State University Established by the Government of Tamil Nadu] KARAIKUDI – 630 003 Directorate of Distance Education M.Sc. [Microbiology] III - Semester 36432 MEDICAL MICROBIOLOGY Copy Right Reserved For Private use only i Author : Dr. S. Rajan Assistant Professor PG and Research Department of Microbiology M. R. Government Arts College Mannargudi -614 001 “The Copyright shall be vested with Alagappa University” All rights reserved. No part of this publication which is material protected by this copyright notice may be reproduced or transmitted or utilized or stored in any form or by any means now known or hereinafter invented, electronic, digital or mechanical, including photocopying, scanning, recording or by any information storage or retrieval system, without prior written permission from the Alagappa University, Karaikudi, Tamil Nadu. Reviewer Dr.G.Selvakumar Assistant professor of Microbiology Directorate of Distance Education Alagappa University Karaikudi ii SYLLABI – BOOK MAPPING TABLE CURRICULUM AND INSTRUCTIONS Syllabi Mapping in book UNIT I Laboratory management 1-17 Safety in containment laboratory Collection and transport of clinical samples UNIT II Microbiological Examination 18-34 Microbiological examination of urine Microbiological examination blood Microbiological examination faeces Microbiological examination cerebrospinal fluid Microbiological examination throat swabs Microbiological examination sputum Microbiological examination pus and wound exudates UNIT III Normal Flora of Human Systems 35-45 General features of normal flora Origin of the normal flora Normal flora of human skin Normal flora of human respiratory tract Normal flora of human gastrointestinal tract Normal flora of human genitourinary tract.
    [Show full text]
  • Dr Jianmin Chen
    Sepsis-induced cardiac dysfunction: Pathophysiology and experimental treatments A thesis presented by Dr Jianmin Chen registered at Barts and The London School of Medicine and Dentistry Queen Mary University of London for the degree of Doctor of Philosophy Centre for Translational Medicine & Therapeutics, The William Harvey Research Institute John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, United Kingdom | ABSTRACT The severity of cardiac dysfunction predicts mortality in septic patients. In this thesis, I have investigated the pathophysiology and the novel therapeutic strategy to attenuate cardiac dysfunction in experimental sepsis. I have developed a model of cardiac dysfunction caused by lipopolysaccharide (LPS)/peptidoglycan (PepG) co-administration or polymicrobial sepsis in young and old, male and female mice. There is good evidence that females tolerate sepsis better than males. Here, I have demonstrated for the first time that the cardiac dysfunction caused by sepsis was less pronounced in female than in male mice; this protection was associated with cardiac activation of a pro-survival pathway [Akt and endothelial nitric oxide synthase], and the decreased activation of a pro-inflammatory signalling pathway [nuclear factor (NF)-κB]. Patients with chronic kidney disease (CKD) requiring dialysis have a higher risk of sepsis and a 100-fold higher mortality. Activation of NF-κB is associated with sepsis- induced cardiac dysfunction and NF-κB is activated by IκB kinase (IKK). Here, I have shown that 5/6th nephrectomy for 8 weeks caused a small, but significant, cardiomyopathy, cardiac activation of NF-κB and expression of inducible nitric oxide synthase (iNOS). When subjected to LPS or polymicrobial sepsis, CKD mice exhibited exacerbation of cardiac dysfunction and cardiac activation of NF-κB and iNOS expression, which were attenuated by a specific IKK inhibitor (IKK 16).
    [Show full text]
  • View the 2020 Index
    Index A Abruptio placentae, 640 for osteoarthritis, 466 Acid phosphatase in neutrophils, 406 A-a gradient cocaine use, 614 toxicity effects, 485 Acid reflux by age, 668 preeclampsia, 643 toxicity treatment for, 248 H2 blockers for, 399 with oxygen deprivation, 669 Abscesses, 479 Acetazolamide, 252, 552, 608 proton pump inhibitors for, 399 restrictive lung disease, 675 acute inflammation and, 214 pseudotumor cerebri, 521 Acid suppression therapy, 398 Abacavir, 203 brain, 156, 177, 180 Acetoacetate metabolism, 90 Acinetobacter baumannii Abciximab calcification with, 211 Acetone breath, 347 highly resistant bacteria, 198 Glycoprotein IIb/IIIa inhibitors, cold staphylococcal, 116 Acetylation nosocomial infections, 142 438 frontal lobe, 153 chromatin, 34 Acinetobacter spp therapeutic antibodies, 122 Klebsiella spp, 145 drug metabolism, 232 nosocomial infections, 185 thrombogenesis and, 411 liver, 155, 179 histones, 34 Acne, 475, 477 Abdominal aorta lung, 685 posttranslation, 45 danazol, 658 atherosclerosis in, 302 necrosis with, 209 Acetylcholine (ACh) tetracyclines for, 192 bifurcation of, 663 Staphylococcus aureus, 135 anticholinesterase effect on, 240 Acquired hydrocele (scrotal), 652 branches, 363 Toxoplasma gondii, 177 change with disease, 495 Acrodermatitis enteropathica, 71 Abdominal aortic aneurysm, 302 treatment of lung, 192 Clostridium botulinum inhibition Acromegaly, 339 Abdominal pain in unvaccinated children, 186 of release, 138 carpal tunnel syndrome, 459 bacterial peritonitis, 390 Absence seizures opioid analgesics, 551 GH, 329
    [Show full text]
  • Pharmacology and Toxicology
    Biogenuix Medsystems Pvt. Ltd. PHARMACOLOGY & TOXICOLOGY Receptors & Transporters Enzyme Modulators • 7-TM Receptors • ATPase & GTPase • Adrenoceptors • Caspase • AMPK / Insulin Receptor • Cyclases • Cannabinoid • Kinases • Dopamine • Phosphatases • Enzyme Linked Receptors • Proteases • GABA • Nuclear Receptors Biochemicals Toxicology • Opioids & Drug • Cardiotoxicity • Serotonin Discovery Peptides • Hematopoietic • Transporters Kits • Hepatotoxicity • Myotoxicity library Toxins • Nephrotoxicity • Venoms Lead Screening Cell Biology • Natural Products • Angiogenesis • Antimicrobials Compound Ion Channels • Apoptosis Libraries • Calcium Channels • Cancer Chemoprevention • CFTR • Cell Cycle • Ionophores • Cell Metabolism • Ligand Gated Ion Channels • Cytoskeleton & Motor Proteins • NMDA Receptors • ECM & Cell Adhesion • Potassium Channels • Epigenetics • Sodium Channels • NSAIDs • TRP Channels • Signal Transduction • Signalling Pathways • Stem Cells ® BIOCHEMICALS & PEPTIDES Ac-D-E Adenosine 5'-diphosphate . disodium salt Aceclofenac Adenosine 5'-diphosphate . potassium salt A Acemetacin Adenosine 5'-monophosphate . disodium salt Acepromazine maleate Adenosine 5'-O-(3-thiotriphosphate) . tetralithium Acetanilide salt Acetaminophen Adenosine 5'-O-thiomonophosphate . dilithium salt Adenosine 5'-triphosphate . disodium salt A-23187, 4 Bromo Acetomycin D,L-1'-Acetoxychavicol Acetate Adenosine-3’,5’-cyclic Monophosphothioate, Rp- A-23187, Ca-Mg Isomer . sodium salt 15-Acetoxyscirpenol A-3 HCL Adenosine-5'-O-(3-thiotriphosphate) . tetralithium
    [Show full text]
  • Inflammatory Responses in Mice After Intratracheal Instillation of Microbes Isolated from Moldy Buildings
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Julkari Inflammatory Responses in Mice after Intratracheal Instillation of Microbes Isolated from Moldy Buildings Juha J. Jussila National Public Health Institute Division of Environmental Health Laboratory of Toxicology P.O.Box 95, FIN-70701 Kuopio, FINLAND and University of Kuopio Department of Pharmacology and Toxicology P.O.Box 1627, FIN-70211 Kuopio, FINLAND Academic dissertation To be presented with permission of the Faculty of Pharmacy of the University of Kuopio for public examination in Auditorium L3 in the Canthia building, University of Kuopio, on Friday 24th January 2003, at 12 o’clock noon. Publisher: National Public Health Institute Mannerheimintie 166 FIN-00300 Helsinki FINLAND Phone +358-9-47441 Fax +358-7-47448408 Author’s address: National Public Health Institute Division of Environmental Health Department of Environmental Medicine Laboratory of Toxicology P.O.Box 95 FIN-70701 Kuopio FINLAND Phone +358-17-201320 Fax +358-17-201265 Email [email protected] Supervisors: Docent Maija-Riitta Hirvonen, Ph.D. Department of Environmental Health National Public Health Institute, Kuopio, Finland Docent Hannu Komulainen, Ph.D. (Pharm.) Department of Environmental Health National Public Health Institute, Kuopio, Finland Professor Jukka Pelkonen, M.D. Department of Clinical Microbiology University of Kuopio, Kuopio, Finland Reviewers: Professor Pekka Saikku, M.D. Department of Medical Microbiology University of Oulu, Oulu, Finland Docent Ilkka Julkunen, M.D. Department of Microbiology National Public Health Institute, Helsinki, Finland Opponent: Professor Kai Savolainen, M.D., Ph.D. Department of Industrial Hygiene and Toxicology Finnish Institute of Occupational Health, Helsinki, Finland ISBN 951-740-331-3 ISSN 0359-3584 ISBN (pdf version) 951-740-332-1 ISSN (pdf version) 1458-6290 Kuopio University Printing Office, Kuopio, Finland, 2003 Jussila, Juha J.
    [Show full text]
  • View the 2021 Index
    Index A ABO hemolytic disease of newborn, idiopathic intracranial Acinetobacter baumannii A-a gradient 415 hypertension, 540 highly resistant bacteria, 198 by age, 692 Abortion mechanism, use and adverse Acne, 489, 491 in oxygen deprivation, 693 antiphospholipid syndrome, 482 effects, 631 danazol, 682 restrictive lung disease, 699 ethical situations, 276 sulfa drug, 255 tetracyclines for, 192 with oxygen deprivation, 693 methotrexate for, 450 Acetoacetate metabolism, 90 Acquired hydrocele (scrotal), 676 Abacavir Abruptio placentae, 664 Acetylation Acrodermatitis enteropathica, 71 HIV terapy, 203 cocaine use, 638 chromatin, 34 Acromegaly HLA subtype hypersensitivity, 100 preeclampsia, 667 drug metabolism, 234 carpal tunnel syndrome, 470 Abciximab Abscesses, 493 histones, 34 findings, diagnosis and treatment, antiplatelets, 447 acute inflammation and, 215 posttranslation, 45 347 mechanism and clinical use, 447 brain, 156, 180 Acetylcholine (ACh) GH, 337 thrombogenesis and, 421 calcification with, 212 anticholinesterase effect on, 244 GH analogs, 336 Abdominal aorta cold staphylococcal, 116 change with disease, 510 octreotide for, 410 and branches, 373 frontal lobe, 153 Clostridium botulinum inhibition somatostatin analogs for, 336 atherosclerosis in, 310 Klebsiella spp, 145 of release, 138 Actin bifurcation of, 687 Staphylococcus aureus, 135 pacemaker action potential and, cytoskeleton, 48, 61 Abdominal aortic aneurysm, 310 liver, 155, 179 301 muscular dystrophies, 61 Abdominal pain lung, 709 Acetylcholine (ACh) receptor Acting out, 576
    [Show full text]